Lawstreet Journal

AYUSH Ministry Cautions Patanjali Over Advertising and Selling Its Alleged Corona Cure ‘Coronil’

Lawstreet Journal 24 Jun 2020 5:45pm

Image courtesy: Lawstreet Journal Executive AYUSH Ministry Cautions Patanjali Over Advertising and Selling Its Alleged Corona Cure ‘Coronil’

On Tuesday 23 June 2020, the Ministry of AYUSH asked the FMGC retail giant Patanjali to furnish details of the medicine ‘Coronil’, which the company claimed to be the cure for the novel coronavirus. The notice came hours after Patanjali launched its medicine through a press conference.

Earlier on Tuesday, Patanjali Founder Baba Ramdev and Managing Director Acharya Balakrishna, in a press conference, claimed that Patanjali Research Institute had developed a medicine that can cure COVID-19. The press conference was held at Patanjali headquarter in Haridwar, Uttarakhand. The research was conducted in collaboration with the National Institute of Medical Science, Jaipur.

“We conducted a clinical case study and clinically controlled trial and found that 69 percent of patients recovered in three days and 100 percent patients recovered in seven days,” Baba Ramdev said. “Coronil has been tested in a randomized placebo-controlled clinical trial on COVID-19 patients, he added. The Yoga guru also claimed that Coronil was the first Ayurvedic, clinically controlled, research, evidenced, and trial based medicine for Covid-19.

However, the Indian Council of Medical Research (ICMR) and AYUSH Ministry have distanced themselves from the alleged cure ‘Coronil’. Commenting on the cure, ICMR, which is the nodal agency for COVID-19 treatment and apex medical body in India, said they do not deal with ayurvedic medicines, AYUSH Ministry does. On the other hand, AYUSH Ministry said that the Uttarakhand government is responsible for granting a license to a pharmaceutical firm, including the Ayurvedic drug manufacturer.

In the notification issued by AYUSH, the Ministry has asked… Continue Reading...


Tagged: Baba Ramdev  
Disclaimer: SoOLEGAL in Media collaboration with Lawstreet Journal. SoOLEGAL take no responsbility for the content provided by Lawstreet Journal. For any discrepancies Contact Lawstreet Journal.
Did you find this write up useful? YES 0 NO 0
Featured Members view all

New Members view all

×

C2RMTo Know More

Something Awesome Is In The Work

0

DAYS

0

HOURS

0

MINUTES

0

SECONDS

Sign-up and we will notify you of our launch.
We’ll also give some discount for your effort :)

* We won’t use your email for spam, just to notify you of our launch.